A detailed history of Gamma Investing LLC transactions in Nkarta, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 4,729 shares of NKTX stock, worth $18,537. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,729
Previous 238 1886.97%
Holding current value
$18,537
Previous $2.57 Million 986.2%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 02, 2024

BUY
$5.27 - $10.82 $23,667 - $48,592
4,491 Added 1886.97%
4,729 $27.9 Million
Q4 2023

Feb 01, 2024

BUY
$1.31 - $6.6 $311 - $1,570
238 New
238 $2.15 Million

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $191M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.